title: Antimicrobial resistance of Campylobacter species isolated from edible bivalve molluscs purchased from Bangkok markets, Thailand.
abstract: Campylobacter species have been recognized as the most commonly reported cause of bacterial gastroenteritis in humans. The increase of resistance rates to drugs of choice used for treatment in campylobacteriosis is becoming a public health concern. In parallel, the increased use of antimicrobials in aquaculture may lead to the emergence of resistant microorganisms and is likely to cause additional health risk to humans through food consumption. The study assesses the presence of antimicrobial resistance in Campylobacter species isolated from three groups of bivalve molluscs (bloody cockles, green mussels, and oysters) purchased from markets in Bangkok. Thirty samples were collected from each group. Susceptibility to three antimicrobials was determined using the Epsilometer test. Rates of erythromycin, nalidixic acid, and ciprofloxacin resistance in Campylobacter isolates were 72-84%, 28-40%, and 21-25%, respectively. There was no statistically significant difference in the prevalence of each antimicrobial resistance between the three groups. This study demonstrates a significant level of antimicrobial resistance in the Campylobacter spp. isolated from molluscs with a particular high rate of resistance to erythromycin. Consumption of raw molluscs contaminated with antimicrobial-resistant Campylobacter spp. may therefore result in resistant infections in humans.
authors.affiliation: Faculty of Public Health, Thammasat University, Pathumthani, 12121 Thailand. snantaka@tu.ac.th
authors.forename: Nantika
authors.initials: N
authors.lastname: Soonthornchaikul
authors.forename: Hemda
authors.initials: H
authors.lastname: Garelick
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002167:Campylobacter / Q000187:drug effects* / Q000235:genetics* / Q000254:growth & development / Q000302:isolation & purification; D002169:Campylobacter Infections / Q000453:epidemiology*; D002939:Ciprofloxacin / Q000494:pharmacology; D024881:Drug Resistance, Bacterial; D004917:Erythromycin / Q000494:pharmacology; D005511:Food Handling / Q000379:methods; D005516:Food Microbiology; D005517:Foodborne Diseases / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D008974:Mollusca / Q000382:microbiology*; D009268:Nalidixic Acid / Q000494:pharmacology; D012758:Shellfish / Q000382:microbiology*; D013785:Thailand
chemical_list: D000900:Anti-Bacterial Agents; D009268:Nalidixic Acid; D002939:Ciprofloxacin; D004917:Erythromycin